When CCL20 binds to its receptor CCR6, it not only participates in regulating the immune homeostasis of the body, but also serves to modulate the inflammatory response through the Th17 pathway, playing an essential role in the progression of autoimmune diseases and various malignant tumors.59, 233, 234. Here, CCL20 is linked to cancer.